Bruker (BRKR) Stock Price, News & Analysis

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BRKR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BRKR, but not buy additional shares or sell existing shares.
View BRKR analyst ratings or view top-rated stocks.

3 equities research analysts have issued 12 month target prices for Bruker's shares. Their BRKR share price targets range from $65.00 to $98.00. On average, they anticipate the company's stock price to reach $82.00 in the next year. This suggests a possible upside of 20.6% from the stock's current price.
View analysts price targets for BRKR or view top-rated stocks among Wall Street analysts.

Bruker's stock was trading at $68.35 on January 1st, 2023. Since then, BRKR stock has decreased by 0.6% and is now trading at $67.97.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 8th 2024.
View our BRKR earnings forecast.

Bruker Co. (NASDAQ:BRKR) released its quarterly earnings data on Thursday, November, 2nd. The medical research company reported $0.74 EPS for the quarter, topping analysts' consensus estimates of $0.63 by $0.11. The medical research company had revenue of $742.80 million for the quarter, compared to the consensus estimate of $718.83 million. Bruker had a trailing twelve-month return on equity of 32.20% and a net margin of 11.32%.

Bruker declared a quarterly dividend on Monday, November 20th. Investors of record on Friday, December 1st will be given a dividend of $0.05 per share on Friday, December 15th. This represents a $0.20 annualized dividend and a yield of 0.29%. The ex-dividend date of this dividend is Thursday, November 30th.
Read our dividend analysis for BRKR.

Bruker (NASDAQ:BRKR) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.29%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 9.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BRKR will have a dividend payout ratio of 7.38% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BRKR.

ETFs with the largest weight of Bruker (NASDAQ:BRKR) stock in their portfolio include ProShares Nanotechnology ETF (TINY), Fidelity Disruptive Medicine ETF (FMED), Franklin Genomic Advancements ETF (HELX), SPDR Kensho Future Security ETF (FITE), Mid Cap US Equity Select ETF (RNMC), SPDR S&P Kensho New Economies Composite ETF (KOMP) and iShares Biotechnology ETF (IBB).iShares U.S. Medical Devices ETF (IHI).

Bruker issued an update on its FY23 earnings guidance on Thursday, November, 2nd. The company provided earnings per share (EPS) guidance of $2.48-2.53 for the period, compared to the consensus EPS estimate of $2.57. The company issued revenue guidance of $2.88-2.91 billion, compared to the consensus revenue estimate of $2.88 billion.

126 employees have rated Bruker Chief Executive Officer Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among the company's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 79.0% of employees surveyed would recommend working at Bruker to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

Bruker's stock is owned by a number of institutional and retail investors. Top institutional shareholders include FMR LLC (7.23%), Massachusetts Financial Services Co. MA (5.34%), RTW Investments LP (2.44%), Fuller & Thaler Asset Management Inc. (1.61%), Invesco Ltd. (1.41%) and Brown Advisory Inc. (1.06%). Insiders that own company stock include Cynthia M Friend, Frank H Laukien, Gerald N Herman, Marc A Kastner, Mark Munch and Richard A Packer.
View institutional ownership trends.

Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.